• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Psychiatry

Cannabis use frequency increased following legalization with a decrease in misuse observed

byJayden BerdugoandAlex Chan
May 2, 2025
in Psychiatry, Public Health
Reading Time: 2 mins read
Parental cannabis use increasing, cigarette use decreasing
Share on FacebookShare on Twitter

1. In this prospective cohort study, cannabis use frequency increased significantly while misuse decreased.  

Evidence Rating Level: 1 (Excellent)

Globally, increasing numbers of jurisdictions are legalizing or plan to legalize the use of recreational cannabis. Canada legalized cannabis in 2018, becoming the first country in the Group of Seven to do so. Before legalization, there were concerns that cannabis use and misuse would increase. Since legalization, there is some evidence that supports this however, other studies have found conflicting results. To address this gap, this study sought to examine the changes in cannabis use and misuse in a cohort of adults since legalization in Canada. Additionally, determining if the frequency of cannabis use before legalization altered the trajectory of use post-legalization. Participants between the ages of 18 to 65 were recruited from St. Joseph’s Healthcare Hamilton in Ontario, Canada. Participants were eligible to participate if they had a minimum ninth-grade education and no terminal illness. The primary outcomes of the study were cannabis use frequency and misuse. To measure cannabis use frequency, participants answered questions from the Canadian Cannabis Survey. To measure cannabis misuse, the 8-item Cannabis Use Disorder Identification Test – Revised (CUDIT-R) scale. A total of 1428 adults were included (mean [SD] age, 34.5 [13.9] years). There was a significant increase in cannabis use frequency (β=0.35; 95% CI, 0.19 to 0.51), to the point that the proportion of days using cannabis increased by 0.35% per year. However, the CUDIT-R scores found a significant decrease in cannabis use frequency overall (β=-0.08 [95% CI, -0.10 to -0.06] per year; P<.001). There was a significant decrease in cannabis use among individuals who were weekly cannabis users at baseline, while there was a slight increase in those who were using cannabis monthly or less. In terms of cannabis product preferences, there were significant decreases in the use of solid and liquid concentrates, cannabis oil, among others, and an increase in the use of edibles, liquids, and disposable vape pens. In summary, this prospective cohort study found an increase in cannabis use and a decrease in misuse. 

Click to read the study in JAMA Network Open

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Tags: addictions medicinecannabispsychiatrypublic healthsubstance misuse
Previous Post

Direct oral anticoagulants increase bleeding risk after intracerebral hemorrhage in patients with atrial fibrillation

Next Post

Alcohol use disorder may be associated with human immunodeficiency virus

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Next Post
Few high school students, young adults get HIV testing

Alcohol use disorder may be associated with human immunodeficiency virus

UTI associated with increased risk of preeclampsia

2 Minute Medicine Rewind May 5, 2025

#VisualAbstract: Baloxavir Treatment is Effective in Preventing Transmission of Influenza

#VisualAbstract: Baloxavir Treatment is Effective in Preventing Transmission of Influenza

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis
  • Physician edits to artificial intelligence (AI)-generated messages to patients were associated with different response time burdens
  • Male sex is associated with higher mortality among patients with hepatocellular carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.